Ezetimibe, an inhibitor of intestinal cholesterol absorption, decreases serum level of malondialdehyde-modified low-density lipoprotein in patients with hypercholesterolemia
書誌事項
- 公開日
- 2011-02
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- https://doi.org/10.15223/policy-017
- https://doi.org/10.15223/policy-037
- https://doi.org/10.15223/policy-012
- https://doi.org/10.15223/policy-029
- https://doi.org/10.15223/policy-004
- DOI
-
- 10.1016/j.ijcard.2010.10.082
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- International Journal of Cardiology
-
International Journal of Cardiology 146 (3), 420-421, 2011-02
Elsevier BV